par Pixmaker | Nov 26, 2025 | Highlight
Nov. 26th, 10am local time in NYC, NASDAQ has featured Eukarÿs on its giant screen in Times Square, for having both: 1 – won the 2025 Grand Prize of Biotools Innovator, the only startup accelerator dedicated to Life Sciences Tools, after an extremely selective...
par Pixmaker | Nov 15, 2025 | Highlight
After an extremely selective process throughout the year 2025 Eukarÿs reaches a historic “double hit” in acceleration programs in the US Eukarÿs is the Winner of the 2025 BioTools Innovator Grand Prize, receiving a $250,000 award. Eukarÿs was in competition with 440...
par Pixmaker | Nov 1, 2025 | Non classé
After having mentored Eukarÿs during the Biotools Innovator acceleration program, Nicole Faust and Bryan Poltilove join the company as strategic advisors. As former CSO and CEO of CEVEC (acquired in 2024 by Cytiva, Danaher group), a world first technology cell line...
par Pixmaker | Juin 1, 2025 | Non classé
One year after the appointment of Gabriel Festocand Anne Lauvergeon as board members, Eukarÿs is pleased to announce a new step in the strengthening of its Board of Directors with the appointment of Eric Drapé. As former EVP Operations of TEVA, Eric brings a deep...
par Pixmaker | Jan 23, 2025 | Non classé
Eukarÿs and Genethon have announced a strategic partnership to reduce the cost of gene therapy drugs production. By combining Eukarÿs’ innovative disruptive C3P3 technology, which enhances unleashes mRNA synthesis in mammalian cells, with Genethon’s...
